Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Open-market sale Chief Legal Officer sold 3,482 shares at $11.41 ($39,730)
  2. 4 Open-market sale Chief Scientific Officer sold 3,489 shares at $12.52 ($43,682)
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. 4 Planned sale Chief Scientific Officer sold 8,000 shares at $15.64 ($125,120)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. 8-K Event Regulation FD disclosure · Other events
  14. 8-K Event Regulation FD disclosure · Other events
  15. 4 Planned sale Chief Scientific Officer sold 8,000 shares at $18.09 ($144,720)
  16. 144 Insider Sale of Securities
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 8 of 24 · 471 filings